214 related articles for article (PubMed ID: 23936210)
1. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
[TBL] [Abstract][Full Text] [Related]
4. T versus D in the MTCXXC motif of copper transport proteins plays a role in directional metal transport.
Niemiec MS; Dingeldein AP; Wittung-Stafshede P
J Biol Inorg Chem; 2014 Aug; 19(6):1037-47. PubMed ID: 24824562
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
[TBL] [Abstract][Full Text] [Related]
6. The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics.
Yu CH; Yang N; Bothe J; Tonelli M; Nokhrin S; Dolgova NV; Braiterman L; Lutsenko S; Dmitriev OY
J Biol Chem; 2017 Nov; 292(44):18169-18177. PubMed ID: 28900031
[TBL] [Abstract][Full Text] [Related]
7. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro.
Kahra D; Mondol T; Niemiec MS; Wittung-Stafshede P
Protein Pept Lett; 2015; 22(6):532-8. PubMed ID: 25962064
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization.
Belviso BD; Galliani A; Lasorsa A; Mirabelli V; Caliandro R; Arnesano F; Natile G
Inorg Chem; 2016 Jul; 55(13):6563-73. PubMed ID: 27305454
[TBL] [Abstract][Full Text] [Related]
9. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
[TBL] [Abstract][Full Text] [Related]
10. Cu(I) Controls Conformational States in Human Atox1 Metallochaperone: An EPR and Multiscale Simulation Study.
Perkal O; Qasem Z; Turgeman M; Schwartz R; Gevorkyan-Airapetov L; Pavlin M; Magistrato A; Major DT; Ruthstein S
J Phys Chem B; 2020 Jun; 124(22):4399-4411. PubMed ID: 32396355
[TBL] [Abstract][Full Text] [Related]
11. Binding of Copper and Cisplatin to Atox1 Is Mediated by Glutathione through the Formation of Metal-Sulfur Clusters.
Dolgova NV; Yu C; Cvitkovic JP; Hodak M; Nienaber KH; Summers KL; Cotelesage JJH; Bernholc J; Kaminski GA; Pickering IJ; George GN; Dmitriev OY
Biochemistry; 2017 Jun; 56(24):3129-3141. PubMed ID: 28549213
[TBL] [Abstract][Full Text] [Related]
12. Conserved residues modulate copper release in human copper chaperone Atox1.
Hussain F; Olson JS; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11158-63. PubMed ID: 18685091
[TBL] [Abstract][Full Text] [Related]
13. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
Xi Z; Guo W; Tian C; Wang F; Liu Y
Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
[TBL] [Abstract][Full Text] [Related]
14. The C-Terminus of Human Copper Importer Ctr1 Acts as a Binding Site and Transfers Copper to Atox1.
Kahra D; Kovermann M; Wittung-Stafshede P
Biophys J; 2016 Jan; 110(1):95-102. PubMed ID: 26745413
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Human Copper Chaperone ATOX1 Bound to Zinc Ion.
Mangini V; Belviso BD; Nardella MI; Natile G; Arnesano F; Caliandro R
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291703
[TBL] [Abstract][Full Text] [Related]
16. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
Brose J; La Fontaine S; Wedd AG; Xiao Z
Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
[TBL] [Abstract][Full Text] [Related]
17. Human cytoplasmic copper chaperones Atox1 and CCS exchange copper ions in vitro.
Petzoldt S; Kahra D; Kovermann M; Dingeldein AP; Niemiec MS; Ådén J; Wittung-Stafshede P
Biometals; 2015 Jun; 28(3):577-85. PubMed ID: 25673218
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
[TBL] [Abstract][Full Text] [Related]
19. Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1.
Tian Y; Fang T; Yuan S; Zheng Y; Arnesano F; Natile G; Liu Y
Metallomics; 2018 May; 10(5):745-750. PubMed ID: 29721562
[TBL] [Abstract][Full Text] [Related]
20. The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.
Levy AR; Turgeman M; Gevorkyan-Aiapetov L; Ruthstein S
Protein Sci; 2017 Aug; 26(8):1609-1618. PubMed ID: 28543811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
